Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) — Boston, Massachusetts

Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) is a clinical research site located in Boston, Massachusetts, United States 02129.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV-1-Infection.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Community Research Initiative of New England d/b/a Community Resource Initiative (CRI)?

Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) conducted?

Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) has 1 clinical trials on record, with 1 currently active. Their work covers HIV-1-Infection.

Is Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) accredited by Crixeo Health?

Community Research Initiative of New England d/b/a Community Resource Initiative (CRI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Community Research Initiative of New England d/b/a Community Resource Initiative (CRI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.